Literature DB >> 8804314

Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter.

D Fitzsimmons1, W Hodsdon, W Wheat, S M Maira, B Wasylyk, J Hagman.   

Abstract

The paired box transcription factor Pax-5 (B-cell-specific activator protein) is a key regulator of lineage-specific gene expression and differentiation in B-lymphocytes. We show that Pax-5 functions as a cell type-specific docking protein that facilitates binding of the early B-cell-specific mb-1 promoter by proteins of the Ets proto-oncogene family. Transcriptional activity of the mb-1 promoter in pre-B-cells is critically dependent on binding sites for Pax-5:Ets complexes. Ternary complex assembly requires only the Pax-5 paired box and ETS DNA-binding domains. Mutation of a single base pair in the ternary complex binding site allows for independent binding by Ets proteins but, conversely, inhibits the binding of Pax-5 by itself. Strikingly, the mutation reverses the pattern of complex assembly: Ets proteins recruit Pax-5 to bind the mutated sequence. Recruitment of Net and Elk-1, but not SAP1a, by Pax-5 defines a functional difference between closely related Ets proteins. Replacement of a valine (V68) in the ETS domain of SAP1a by aspartic acid (as found in c-Ets-1, Elk-1, and Net) enhanced ternary complex formation by more than 60-fold. Together, these observations define novel transcription factor interactions that regulate gene expression in B cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8804314     DOI: 10.1101/gad.10.17.2198

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  75 in total

1.  The ETS domain factor Pet-1 is an early and precise marker of central serotonin neurons and interacts with a conserved element in serotonergic genes.

Authors:  T Hendricks; N Francis; D Fyodorov; E S Deneris
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

2.  Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding.

Authors:  E C Roberts; R W Deed; T Inoue; J D Norton; A D Sharrocks
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

3.  The mechanism of complex formation between Fli-1 and SRF transcription factors.

Authors:  P Dalgleish; A D Sharrocks
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

4.  BSAP can repress enhancer activity by targeting PU.1 function.

Authors:  S Maitra; M Atchison
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  Pax6 and SOX2 form a co-DNA-binding partner complex that regulates initiation of lens development.

Authors:  Y Kamachi; M Uchikawa; A Tanouchi; R Sekido; H Kondoh
Journal:  Genes Dev       Date:  2001-05-15       Impact factor: 11.361

6.  Crystal structure of the human Pax6 paired domain-DNA complex reveals specific roles for the linker region and carboxy-terminal subdomain in DNA binding.

Authors:  H E Xu; M A Rould; W Xu; J A Epstein; R L Maas; C O Pabo
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

7.  Activation of the early B-cell-specific mb-1 (Ig-alpha) gene by Pax-5 is dependent on an unmethylated Ets binding site.

Authors:  Holly Maier; Jeff Colbert; Daniel Fitzsimmons; Dawn R Clark; James Hagman
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

8.  Methylation of an ETS site in the intron enhancer of the keratin 18 gene participates in tissue-specific repression.

Authors:  A Umezawa; H Yamamoto; K Rhodes; M J Klemsz; R A Maki; R G Oshima
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

9.  WBP-2, a WW domain binding protein, interacts with the thyroid-specific transcription factor Pax8.

Authors:  Roberto Nitsch; Tina Di Palma; Anna Mascia; Mariastella Zannini
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

10.  B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.

Authors:  Diana Cozma; Duonan Yu; Suchita Hodawadekar; Anna Azvolinsky; Shannon Grande; John W Tobias; Michele H Metzgar; Jennifer Paterson; Jan Erikson; Teresa Marafioti; John G Monroe; Michael L Atchison; Andrei Thomas-Tikhonenko
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.